Lilly To Pay Up To $690 Mil. To Settle Majority Of Zyprexa Injury Claims
This article was originally published in The Pink Sheet Daily
Executive Summary
Settlement will cover approximately 8,000 personal injury claims regarding diabetes and hyperglycemia, or about 75% of the total number of cases, Lilly says. “Lilly is prepared to continue its vigorous defense of Zyprexa in the remaining cases,” the company said.